Searchable abstracts of presentations at key conferences in endocrinology

ea0011p869 | Thyroid | ECE2006

Identification of housekeeping genes useful for the normalization of rna in studies of gene expression in thyroid carcinomas

Piampiani P , Romei C , Cosci B , Vivaldi A , Ciampi R , Pinchera A , Elisei R

Housekeeping genes (HK) are commonly used as controls for the normalization of the RNA amount in quantitative RT-PCR experiments. The question whether their expression is influenced by the metabolic state of the patient and/or the tumour transformation is still unresolved and until now, HK genes have been used in quantitative studies without considering that their expression could be different in tumor with respect to normal tissue. Aim of this study was to identify HK genes e...

ea0011p873 | Thyroid | ECE2006

17-AAG and DIDS increase the iodide retention time in thyroid cancer cells transfected with NIS

Vivaldi A , Ciampi R , Santini F , Cosci B , Piampiani P , Romei C , Pinchera A , Elisei R

Background: One of the major limits of gene therapy with sodium iodide symporter (NIS), which enables cells to be subjected to radioiodine therapy, is that NIS transfected cells rapidly release the intracellular iodine.Materials and methods: We transfected two human anaplastic (FRO) and medullary (TT) thyroid cancer derived cell lines, unable to take up iodine, with human NIS cDNA. The possibility of increasing the iodine retention time by treating cells...

ea0011p874 | Thyroid | ECE2006

Demethylating treatment with azacytidine induces retinoic acid receptor RAR beta expression in human thyroid cancer cells

Miasaki FY , Vivaldi A , Ciampi R , Agate L , Cosci B , Piampiani P , Romei C , Pinchera A , Elisei R

We previously found that two cell lines (ARO and FRO) derived from anaplastic thyroid cancer and one (TT) deriving from medullary thyroid cancer did not respond to the retinoic acid (RA) treatment. We supposed that it was related to the lack of the RA receptor RAR beta mRNA expression. It has been suggested that the promoter methylation was one possible cause of loss of RAR beta expression.We analyzed the methylation status of RAR beta promoter in ARO, F...

ea0011p870 | Thyroid | ECE2006

Identification of a novel germ-line point mutation of the ret gene (Met848Thr) in a patient affected by medullary thyroid carcinoma and castleman’s syndrome

Cosci B , Altea M , Castagna M , Romei C , Piampiani P , Vivaldi A , Ciampi R , Faviana P , Basolo F , Pinchera A , Elisei R

Mutations in the RET proto-oncogene are responsible for multiple endocrine neoplasia type II. Somatic RET mutations were described in 50% of medullary thyroid carcinoma (MTC). We describe here a novel germline mutation of the RET gene detected in an apparentely sporadic MTC.The index case was a 67 years old patient who arrived at our observation for a bilateral laterocervical linfoadenopathy. The patient was clinically evaluated for thyroid function and ...